These 6 drugmakers froze price hikes in response to Trump’s criticism

(By Alia Paavola for Becker’s Hospital Review)

The pharmaceutical industry is facing increased pressure from President Donald Trump, lawmakers and the public to lower drug prices. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.